Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
2
×
detroit blog main
detroit top stories
fda
2
×
indiana blog main
indiana top stories
keytruda
2
×
life sciences
merck
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
2
×
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
array biopharma
astrazeneca
barcelona
beacon
biotech
bladder
blueprint medicines
bristol-myers squibb
What
cancer
annual
approved
ash
barcelona
clinical
conference
december's
deeper
dna
drug
esmo
european
fda
fingerprint
genetic
going
kras
major
matter
medical
medicine
meeting
nd
new
oks
oncology
parp
prostate
seagen’s
second
society
targets
time
tissues
tumor's
update
win
world
wrapped
Language
unset
Current search:
keytruda
×
cancer
×
fda
×
" seattle blog main "
×
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues